Diagnosis of prostate cancer with magneticresonance imaging in men treated with 5-alpha-reductase inhibitors

4. Falagario UG;Lantz A;Jambor I;Busetto GM;Bettocchi C;Finati M;Ricapito A;Luzzago S;Ferro M;Musi G;Totaro A;Racioppi M;Carbonara U;Checcucci E;Manfredi M;D'Aietti D;Porcaro AB;Nordström T;Björnebo L;Oderda M;Soria F;Taimen P;Aronen HJ;Perez IM;Ettala O;Marchioni M;Simone G;Ferriero M;Brassetti A;Napolitano L;Carmignani L;Signorini C;Conti A;Ludovico G;Scarcia M;Trombetta C;Claps F;Traunero F;Montanari E;Boeri L;Maggi M;Del Giudice F;Bove P;Forte V;Ficarra V;Rossanese M;Mucciardi G;Pagliarulo V;Tafuri A;Mirone V;Schips L;Antonelli A;Gontero P;Cormio L;Sciarra A;Porpiglia F;Bassi P;Ditonno P;Boström PJ;Messina E;Panebianco V;De Cobelli O;Carrieri G;PROMOD Study Group.

2023-01-01